WO2026132913 - AN IMPROVED PROCESS OF PREPARATION OF GLP/GIP ANALOGUES
National phase entry is expected:
Publication Number
WO/2026/132913
Publication Date
25.06.2026
International Application No.
PCT/IB2025/050874
International Filing Date
27.01.2025
Title **
[English]
AN IMPROVED PROCESS OF PREPARATION OF GLP/GIP ANALOGUES
[French]
PROCÉDÉ AMÉLIORÉ DE PRÉPARATION D'ANALOGUES GLP/GIP
Applicants **
ALEMBIC PHARMACEUTICALS LIMITED
Inventors
RAMU, Vasanthakumar Ganga
PONNUSAMY, Thangarasu
CHAITANYA, Krishna
MARATA, Subashrao
GALIPALLI, Ramu
YERRAPRAGADA, Pavan Aditya
KISHORE, Balla
Priority Data
202421099494
16.12.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2341 | |
| EPO | Filing, Examination, Granting | 13326 | |
| Japan | Filing, Examination, Granting | 2214 | |
| South Korea | Filing, Examination, Granting | 2270 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
26,691
Contact Us
Abstract[English]
The present invention relates to an efficient process for the preparation of Tirzepatide, or a pharmaceutically acceptable salt thereof. The present invention also relates to novel fragments as intermediates and use thereof in the preparation of Tirzepatide.[French]
La présente invention concerne un procédé efficace pour la préparation du Tirzépatide, ou d'un sel pharmaceutiquement acceptable de celui-ci. La présente invention concerne également de nouveaux fragments en tant qu'intermédiaires et leur utilisation dans la préparation du Tirzépatide.